StockWatch
·
Healthcare Research- Analytics & Technology
Corporate Governance11 Nov 2026, 06:20 pm

Jeevan Scientific: No deviation in preferential allotment funds

AI Summary

Jeevan Scientific Technology Ltd has reported that there were no deviations or variations in the utilization of funds raised through a preferential allotment during the quarter ended September 30, 2026. The company raised ₹3,074 Lakhs (₹30.74 Crore) on January 2, 2026. The funds were allocated across various purposes including Capital Expenditure, Working Capital, acquisition of API/formulation units, and General Corporate Purposes. The actual utilization for these purposes during the quarter was within the allocated amounts, with no significant variances reported.

Key Highlights

  • No deviation reported in preferential allotment fund utilization for Q3 FY27.
  • Total funds raised via preferential allotment: ₹3,074 Lakhs (₹30.74 Crore).
  • Funds utilized for capital expenditure, working capital, and acquisitions.
  • No shareholder approval required for any deviation.